GHP Investment Advisors Inc. lifted its position in MEDNAX Inc (NYSE:MD) by 13.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 7,735 shares of the company’s stock after purchasing an additional 940 shares during the quarter. GHP Investment Advisors Inc.’s holdings in MEDNAX were worth $413,000 at the end of the most recent quarter.
Several other institutional investors have also recently added to or reduced their stakes in MD. Prudential Financial Inc. increased its stake in MEDNAX by 976.9% in the third quarter. Prudential Financial Inc. now owns 641,057 shares of the company’s stock valued at $27,642,000 after acquiring an additional 581,527 shares during the last quarter. Quantbot Technologies LP bought a new position in MEDNAX in the third quarter valued at $695,000. Point72 Asset Management L.P. increased its stake in MEDNAX by 71.7% in the third quarter. Point72 Asset Management L.P. now owns 132,700 shares of the company’s stock valued at $5,722,000 after acquiring an additional 55,400 shares during the last quarter. Advisor Group Inc. increased its stake in MEDNAX by 41.9% in the third quarter. Advisor Group Inc. now owns 8,361 shares of the company’s stock valued at $359,000 after acquiring an additional 2,468 shares during the last quarter. Finally, American International Group Inc. increased its stake in MEDNAX by 1.2% in the fourth quarter. American International Group Inc. now owns 197,889 shares of the company’s stock valued at $10,575,000 after acquiring an additional 2,306 shares during the last quarter. 98.53% of the stock is currently owned by hedge funds and other institutional investors.
NYSE MD opened at $54.67 on Friday. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 0.60. The stock has a market cap of $5,178.45, a price-to-earnings ratio of 17.36, a price-to-earnings-growth ratio of 1.37 and a beta of 0.23. MEDNAX Inc has a 12-month low of $40.56 and a 12-month high of $68.55.
MEDNAX (NYSE:MD) last posted its earnings results on Thursday, February 8th. The company reported $0.87 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.83 by $0.04. The company had revenue of $910.82 million during the quarter, compared to analyst estimates of $884.55 million. MEDNAX had a net margin of 9.26% and a return on equity of 10.10%. MEDNAX’s revenue for the quarter was up 9.6% on a year-over-year basis. During the same period in the prior year, the business posted $1.00 earnings per share. sell-side analysts predict that MEDNAX Inc will post 4.02 earnings per share for the current fiscal year.
A number of research analysts recently commented on MD shares. TheStreet raised MEDNAX from a “c+” rating to a “b” rating in a research note on Monday, March 12th. Zacks Investment Research raised MEDNAX from a “hold” rating to a “buy” rating and set a $60.00 target price on the stock in a research note on Tuesday, January 23rd. Stephens set a $62.00 target price on MEDNAX and gave the company a “buy” rating in a research note on Thursday, February 8th. Jefferies Group set a $58.00 target price on MEDNAX and gave the company a “hold” rating in a research note on Thursday, March 15th. Finally, Mizuho set a $49.00 price target on shares of MEDNAX and gave the company a “hold” rating in a research report on Wednesday, January 24th. Three analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the company. MEDNAX currently has a consensus rating of “Hold” and an average price target of $55.69.
In other news, insider John C. Pepia sold 3,000 shares of the stock in a transaction dated Tuesday, March 13th. The shares were sold at an average price of $58.35, for a total transaction of $175,050.00. Following the completion of the sale, the insider now directly owns 39,716 shares in the company, valued at $2,317,428.60. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 2.40% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “GHP Investment Advisors Inc. Has $413,000 Stake in MEDNAX Inc (MD)” was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this news story on another website, it was illegally stolen and reposted in violation of US & international trademark & copyright law. The correct version of this news story can be accessed at https://www.dispatchtribunal.com/2018/04/07/ghp-investment-advisors-inc-increases-stake-in-mednax-inc-md.html.
MEDNAX, Inc is a provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. As of December 31, 2016, the Company’s national network consisted of over 3,600 affiliated physicians, including over 1,130 physicians providing neonatal clinical care, in 35 states and Puerto Rico, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications.
Receive News & Ratings for MEDNAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MEDNAX and related companies with MarketBeat.com's FREE daily email newsletter.